Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Medela Potentia Tbk. (MDLA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Medela Potentia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Medela Potentia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Medela Potentia Tbk. trades at Rp210 (market cap 2.97T, 772.4K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 4.7× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 772.4K). Which is the better fit depends on your goals.

LABSMDLA
Market Cap
635.95B2.97T
Volume
843K772.4K
Lot
8.43K7.72K
Turnover
137.6M161.92M
Average Price
163.22209.64
Value
137.6M161.92M
Indicative Equilibrium Price
165210
Indicative Equilibrium Volume
2462

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MDLA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Medela Potentia Tbk.

PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.

Read more on MDLA